Summit X, LLC
- SEC CIK
- 0001697729
- Latest filing
- Nov 13, 2025
RVNC holding history
Revance Therapeutics, Inc. in every 13F filed by Summit X, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVNC overviewAll 13F holders of RVNCFull Q3 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −88,244−100.0% | Sold out | Holders |
| Q3 2024 | 88,244 | $226.8K | 0.1% | −151−0.2% | Reduced | Holders |
| Q2 2024 | 88,395 | $227.4K | 0.1% | +54,961+164.4% | Added | Holders |
| Q1 2024 | 33,434 | $164.5K | <0.1% | +16,046+92.3% | Added | Holders |
| Q4 2023 | 17,388 | $152.8K | <0.1% | −257−1.5% | Reduced | Holders |
| Q3 2023 | 17,645 | $202.5K | 0.1% | +858+5.1% | Added | Holders |
| Q2 2023 | 16,787 | $425.1K | 0.1% | −1,210−6.7% | Reduced | Holders |
| Q1 2023 | 17,997 | $579.6K | 0.1% | +17,997 | New | Holders |